HippoFi Inc. Stock Analysis ORHB
HippoFi, Inc. is a healthcare innovator, delivering proprietary technologies in the multi-billion-dollar Spine, Orthopedic, and Cancer markets. The company is headquartered in Irvine, California. The company went IPO on 2006-08-01. The firm is engaged in delivering proprietary technologies in the multi-billion-dollar Spine, Orthopedic and Cancer markets. The company is focused on improving patient care and outcomes by utilizing biotech and AI technologies to address degenerative and diseased conditions affecting the quality of life. Its business is designed to drive the Company’s value by commercializing and monetizing advanced solutions, acquiring assets, and licensing technologies, establishing strategic partnerships and industry alliances, and leveraging worldwide sales channels. Its operations comprise two segments: Regenerative Therapeutics and Intelligent Automation. Regenerative Therapeutics division is actively developing and deploying scalable biological solutions into the biotechnology market through its wholly owned subsidiary, PUR Biologics, LLC (PUR). The company is also focused on implementing solutions in the Biotech, Fintech, and AI markets.
Read More HippoFi Inc (ORHB) Chart
Key Statistics of HippoFi Inc (ORHB)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
11.28KP/E Ratio (TTM)
-52 Week Range
Market Cap
427.78KAvg. Volume
53.72KDividend Yield
-Financial Metrics & Statements of HippoFi Inc (ORHB)
FAQ's for HippoFi Inc (ORHB)
- According to Musaffa’s Shariah screening methodology, HippoFi Inc (ORHB) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.